Safety and Efficacy Study of Nab-paclitaxel Plus Gemcitabine in Chinese Patients With Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Gemcitabine
Related studies linked through entity extraction aliases.
Phase 1/2 Study of ABI-009 in Nonmuscle Invasive Bladder Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of Herceptin (Trastuzumab) Combination Therapy in Patients With Metastatic Urothelial Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Metformin Combined With Gemcitabine as Adjuvant Therapy for Pancreatic Cancer After Curative Resection
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Vantictumab (OMP-18R5) in Combination With Nab-Paclitaxel and Gemcitabine in Previously Untreated Stage IV Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate the Effect of the Combination of Pertuzumab With Carboplatin-Based Standard Chemotherapy in Patients With Recurrent Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Tarceva (Erlotinib) in Combination With Platinum Based Chemotherapy in Patients With Non-Small Cell Lung Cancer.
- Status
- COMPLETED
- Phase
- PHASE2
GAD-M Regimen As First-Line Treatment in Untreated Extranodal NK/T Cell Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
The Role of the Tumor Microenvironment of Pancreatic Cancer to Predict Treatment Outcome
- Status
- COMPLETED
- Phase
- NA
Aza-SAHA-GBM With AutoSCT for Refractory Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Randomized Phase II Trial of Pre-Operative Gemcitabine and Nab Paclitacel With or With Out Hydroxychloroquine
- Status
- COMPLETED
- Phase
- PHASE2
Non-comparative Study of Treatment With Induction Chemotherapy With Cisplatin and Gemcitabine Followed by Chemoradiation or Definitive Chemoradiation in Invasive Locally Advanced Carcinomas of Uterine Cervix.
- Status
- UNKNOWN
- Phase
- PHASE2
Safety Feasibility and Effect of TTFields (150 kHz) Concomitant With Gemcitabine or Concomitant With Gemcitabine Plus Nab-paclitaxel for Front-line Therapy of Advanced Pancreatic Adenocarcinoma (PANOVA)
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Escalating Doses of PM01183 in Combination With Gemcitabine in Patients With Specific Unresectable Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy of ABI-007 Plus Gemcitabine or sLV5FU2 as First-line Therapy in Patients With Metastatic Pancreatic Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the "Apact" Study)
- Status
- COMPLETED
- Phase
- PHASE3
Phase 3 Trial of 90Y-Clivatuzumab Tetraxetan & Gemcitabine vs Placebo & Gemcitabine in Metastatic Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE3
A Clinical Study in Three-arm of Lurbinectedin (PM01183) Alone or in Combination With Gemcitabine and a Control Arm With Docetaxel as Second Line Treatment in Non-Small Cell Lung Cancer (NSCLC) Patients
- Status
- COMPLETED
- Phase
- PHASE2
Selumetinib (AZD6244, ARRY-142886) J-BTC Phase 1 Study
- Status
- TERMINATED
- Phase
- PHASE1
Phase Ib/II Trials of RAD001 in Triple Negative Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2